| Literature DB >> 31191486 |
Yi-Ming Wang1, Wen-Long Dong1, Kokou Ayefounin Odah1, Ling-Cong Kong1, Hong-Xia Ma1.
Abstract
Eugenol, the major active essential oil component of clove, was reported to possess QS (quorum sensing) inhibitory activity. A previous study found that eugenol could bind to quorum sensing receptors of Pseudomonas aeruginosa and down-regulate the expression of Streptococcus mutans virulence genes at sub-MIC (minimum inhibitory concentration) without affecting the bacterial growth. However, the alterations of QS signal molecules at transcription levels was not well understood. To better understand interactions of Klebsiella pneumoniae in response to eugenol and explore molecular regulations, transcriptome sequencing was performed. A total of 5779 differentially expressed genes (DEGs) enriched in a variety of biological processes and pathways were identified. The transcriptional data was validated by qPCR and the results showed that the expression profiles of 4 major genes involved in autoinducers-2 (AI-2) synthesis, including luxS, pfs, and lsrK were consistent with transcriptome analysis except for lsrR, a transcriptional repressor gene of lsr operon, which may repress the expression of following genes responsible for AI-2 signal transmission in vivo. In vitro AI-2 synthesis assay also revealed that eugenol could inhibit AI-2 generation. The results of our study offer insights into the mechanisms of QS inhibitory activity and K. pneumoniae AI-2 alterations after eugenol treatment.Entities:
Keywords: AI-2 synthesis; K. pneumoniae; eugenol; inhibitory effect; quorum sensing; transcriptome analysis
Year: 2019 PMID: 31191486 PMCID: PMC6547871 DOI: 10.3389/fmicb.2019.01159
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Chemical structure of eugenol.
Sequences of primers used in this study.
| Primer name | Sequence (5′-3′) | Product size (bp) |
|---|---|---|
| ACGCCATTACCGTTAAGATG | 81 ( | |
| AGTGATGCCAGAAAGAGGGA | ||
| CGGCAACAGCCAGGAACTCA | 169 ( | |
| GCGAAAATCCGCCACAACTT | ||
| AGATCCATCGGGAACTGC | 115 | |
| CCAATCAGAGCGGCATAA | ||
| GCATTCGGGCGGTTATTT | 124 | |
| TGCCAGTTGGTGGTAAGG | ||
| 16SrRNA-F | TGTCGTCAGCTCGTGTTGTG | 130 |
| 16SrRNA-R | ATCCCCACCTTCCTCCAGTT |
Antimicrobial resistance profile of clinical K. pneumoniae isolate.
| Antibiotics used | Antimicrobial resistance∗ |
|---|---|
| AMO | R |
| AZM | S |
| AZL | R |
| AZT | S |
| CFZ | S |
| CHL | S |
| CTX | S |
| DOX | S |
| FRZ | I |
| GEN | S |
| IPM | S |
| KAN | S |
| LVX | S |
| OXA | R |
| NOR | S |
| POL | S |
| STR | S |
FIGURE 2Volcano graph of DEGs (A) and up-regulated and down-regulated genes (B) between eugenol treated group (EK1) and control group (CK1).
FIGURE 3DEGs of biological process, cellular component and molecular function GO terms.
FIGURE 4Statistical enrichment of DEGs in KEGG pathways.
FIGURE 5Relative expression of AI-2 relevant genes. luxS (A), pfs (B), lsrR (C), lsrK (D). All data were expressed as mean ± SD., n = 3. ∗∗P < 0.01 vs. control group.
FIGURE 6Absorption of homocysteine incubated with different concentrations eugenol. ∗P < 0.05 vs. control group.
FIGURE 7Pearson’s correlation coefficient and volcano graph of eugenol treated group (EK1) and control group (CK1).
FIGURE 8Heatmap expression pattern clustering analysis of eugenol treated group (EK1) and control group (CK1).